Competition for Herceptin biosimilar heats up in Europe
European Medicines Agency (EMA) has recommended approval to Pfizers Trastuzumab biosimilar. Biocon/Mylan have also awaiting approval on Herceptin biosimilar in EU.from India Infoline News Service https://ift.tt/2HukiLI
Comments
Post a Comment